A New Jersey-based pharmaceutical firm that acquired the Aptuit operation in south Kansas City three years ago is planning to hire an additional 230 employees over the next five years.
Catalent Pharma Solutions, which currently employs about 50 people at 10245 Hickman Mills Drive, has received a state job-training grant. It will assist Catalent’s plan to hire the 230 people, Rachel Wolf, Catalent’s human relations director, said Monday.
Missouri Gov. Jay Nixon and Kansas City Mayor Sly James are to discuss the expansion at an event Tuesday afternoon at the 450,000-square-foot Catalent facility. The company is described as a global leader in the life sciences industry. The building is part of the former Marion Laboratories complex, which also includes the Cerner Innovation Campus.
The firm’s website describes Catalent’s Kansas City operation as a facility that provides customers with a wide range of fully integrated support, from formulation development and analytical testing to clinical supply services, as well as clinical and commercial manufacturing for oral dose forms.
Catalent acquired the Kansas City operation from Aptuit in 2011.